Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Olmesartan). Showing records 1 – 6 of 6 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters

1. Ito, Satoyasu; Ozawa, Kentaro; Zhao, Jing; Kyotani, Yoji; Nagayama, Kosuke. Olmesartan inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch through the inhibition of the c-Jun N-terminal kinase and p38 signaling pathways. : オルメサルタンは、JNK及びp38シグナル経路を抑制することで、周期的機械的伸展による培養大動脈平滑筋細胞死を抑制する.

Degree: 博士(医学), 2015, Nara Medical University / 奈良県立医科大学

Acute aortic dissection (AAD) is a life-threating disease; however, there is almost no effective pharmacotherapy for it. An increase in c-Jun N-terminal kinase (JNK) phosphorylation… (more)

Subjects/Keywords: Stretch; c-Jun N-terminal kinase; p38; Acute aortic dissection; Olmesartan

Page 1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ito, Satoyasu; Ozawa, Kentaro; Zhao, Jing; Kyotani, Yoji; Nagayama, K. (2015). Olmesartan inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch through the inhibition of the c-Jun N-terminal kinase and p38 signaling pathways. : オルメサルタンは、JNK及びp38シグナル経路を抑制することで、周期的機械的伸展による培養大動脈平滑筋細胞死を抑制する. (Thesis). Nara Medical University / 奈良県立医科大学. Retrieved from http://hdl.handle.net/10564/2939

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ito, Satoyasu; Ozawa, Kentaro; Zhao, Jing; Kyotani, Yoji; Nagayama, Kosuke. “Olmesartan inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch through the inhibition of the c-Jun N-terminal kinase and p38 signaling pathways. : オルメサルタンは、JNK及びp38シグナル経路を抑制することで、周期的機械的伸展による培養大動脈平滑筋細胞死を抑制する.” 2015. Thesis, Nara Medical University / 奈良県立医科大学. Accessed May 20, 2019. http://hdl.handle.net/10564/2939.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ito, Satoyasu; Ozawa, Kentaro; Zhao, Jing; Kyotani, Yoji; Nagayama, Kosuke. “Olmesartan inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch through the inhibition of the c-Jun N-terminal kinase and p38 signaling pathways. : オルメサルタンは、JNK及びp38シグナル経路を抑制することで、周期的機械的伸展による培養大動脈平滑筋細胞死を抑制する.” 2015. Web. 20 May 2019.

Vancouver:

Ito, Satoyasu; Ozawa, Kentaro; Zhao, Jing; Kyotani, Yoji; Nagayama K. Olmesartan inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch through the inhibition of the c-Jun N-terminal kinase and p38 signaling pathways. : オルメサルタンは、JNK及びp38シグナル経路を抑制することで、周期的機械的伸展による培養大動脈平滑筋細胞死を抑制する. [Internet] [Thesis]. Nara Medical University / 奈良県立医科大学; 2015. [cited 2019 May 20]. Available from: http://hdl.handle.net/10564/2939.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ito, Satoyasu; Ozawa, Kentaro; Zhao, Jing; Kyotani, Yoji; Nagayama K. Olmesartan inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch through the inhibition of the c-Jun N-terminal kinase and p38 signaling pathways. : オルメサルタンは、JNK及びp38シグナル経路を抑制することで、周期的機械的伸展による培養大動脈平滑筋細胞死を抑制する. [Thesis]. Nara Medical University / 奈良県立医科大学; 2015. Available from: http://hdl.handle.net/10564/2939

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Virginia Tech

2. Marinik, Elaina. Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure.

Degree: PhD, Human Nutrition, Foods, and Exercise, 2012, Virginia Tech

 Currently, it is reported that ~65% and 34% of the U.S. population is overweight and obese, respectively. Obesity is a major risk factor for cardiovascular… (more)

Subjects/Keywords: olmesartan; hypertension; renin-angiotensin system; insulin resistance; type 2 diabetes

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Marinik, E. (2012). Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure. (Doctoral Dissertation). Virginia Tech. Retrieved from http://hdl.handle.net/10919/37369

Chicago Manual of Style (16th Edition):

Marinik, Elaina. “Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure.” 2012. Doctoral Dissertation, Virginia Tech. Accessed May 20, 2019. http://hdl.handle.net/10919/37369.

MLA Handbook (7th Edition):

Marinik, Elaina. “Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure.” 2012. Web. 20 May 2019.

Vancouver:

Marinik E. Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure. [Internet] [Doctoral dissertation]. Virginia Tech; 2012. [cited 2019 May 20]. Available from: http://hdl.handle.net/10919/37369.

Council of Science Editors:

Marinik E. Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure. [Doctoral Dissertation]. Virginia Tech; 2012. Available from: http://hdl.handle.net/10919/37369

3. Kyotani, Yoji; Zhao, Jing; Tomita, Sayuko; Nakayama, Hitoshi; Isosaki, Minoru; Uno, Masayuki. Olmesartan inhibits angiotensin II-induced migration of vascular smooth muscle cells through Src and MAP kinase pathways : アンジオテンシンⅡによるSrc及びmitogen-activated protein kinaseを介した血管平滑筋細胞の遊走に対するオルメサルタンの阻害作用.

Degree: Nara Medical University / 奈良県立医科大学

Clinical studies have shown that Angiotensin receptor blockers (ARBs) reduce the risk of cardiovascular diseases in hypertensive patients. It is assumed that the reduction of… (more)

Subjects/Keywords: angiotensin II; angiotensin receptor blocker; ARB; olmesartan; cell migration

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kyotani, Yoji; Zhao, Jing; Tomita, Sayuko; Nakayama, Hitoshi; Isosaki, Minoru; Uno, M. (n.d.). Olmesartan inhibits angiotensin II-induced migration of vascular smooth muscle cells through Src and MAP kinase pathways : アンジオテンシンⅡによるSrc及びmitogen-activated protein kinaseを介した血管平滑筋細胞の遊走に対するオルメサルタンの阻害作用. (Thesis). Nara Medical University / 奈良県立医科大学. Retrieved from http://hdl.handle.net/10564/2103

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kyotani, Yoji; Zhao, Jing; Tomita, Sayuko; Nakayama, Hitoshi; Isosaki, Minoru; Uno, Masayuki. “Olmesartan inhibits angiotensin II-induced migration of vascular smooth muscle cells through Src and MAP kinase pathways : アンジオテンシンⅡによるSrc及びmitogen-activated protein kinaseを介した血管平滑筋細胞の遊走に対するオルメサルタンの阻害作用.” Thesis, Nara Medical University / 奈良県立医科大学. Accessed May 20, 2019. http://hdl.handle.net/10564/2103.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kyotani, Yoji; Zhao, Jing; Tomita, Sayuko; Nakayama, Hitoshi; Isosaki, Minoru; Uno, Masayuki. “Olmesartan inhibits angiotensin II-induced migration of vascular smooth muscle cells through Src and MAP kinase pathways : アンジオテンシンⅡによるSrc及びmitogen-activated protein kinaseを介した血管平滑筋細胞の遊走に対するオルメサルタンの阻害作用.” Web. 20 May 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Kyotani, Yoji; Zhao, Jing; Tomita, Sayuko; Nakayama, Hitoshi; Isosaki, Minoru; Uno M. Olmesartan inhibits angiotensin II-induced migration of vascular smooth muscle cells through Src and MAP kinase pathways : アンジオテンシンⅡによるSrc及びmitogen-activated protein kinaseを介した血管平滑筋細胞の遊走に対するオルメサルタンの阻害作用. [Internet] [Thesis]. Nara Medical University / 奈良県立医科大学; [cited 2019 May 20]. Available from: http://hdl.handle.net/10564/2103.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Kyotani, Yoji; Zhao, Jing; Tomita, Sayuko; Nakayama, Hitoshi; Isosaki, Minoru; Uno M. Olmesartan inhibits angiotensin II-induced migration of vascular smooth muscle cells through Src and MAP kinase pathways : アンジオテンシンⅡによるSrc及びmitogen-activated protein kinaseを介した血管平滑筋細胞の遊走に対するオルメサルタンの阻害作用. [Thesis]. Nara Medical University / 奈良県立医科大学; Available from: http://hdl.handle.net/10564/2103

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

4. Ντουντανιώτης, Δημήτριος. Διαμορφωτική μελέτη αντιυπερτασικών φαρμάκων και αλληλεπιδράσεις τους με λιποειδείς διπλοστιβάδες με χρήση φυσικοχημικών μεθόδων.

Degree: 2012, University of Patras

Η υπέρταση είναι ένας από τους σημαντικότερους παράγοντες που αυξάνει τα καρδιαγγειακά επεισόδια τα οποία ευθύνονται περίπου για το ήμισυ των θανατηφόρων επεισοδίων στους ενήλικους.… (more)

Subjects/Keywords: Ολμεσαρτάνη; Αλισκιρένη; Διπλοστιβάδες διπαλμιτικής φωσφατιδυλοχολίνης; Διαφορική θερμιδομετρία σάρωσης; Πυρηνικός μαγνητικός συντονισμός στερεής κατάστασης; Φασματοσκοπία Raman; Περίθλαση ακτίνων-X; Μεθυλαιθέρας της ολμεσαρτάνης; 615.71; Olmesartan; Aliskiren; Dipalmitoylphosphatidylcholine (DPPC) bilayers; Differential scanning calorimetry; Solid state NMR; Raman spectroscopy; X-ray diffraction; Methylated ether of olmesartan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ντουντανιώτης, . (2012). Διαμορφωτική μελέτη αντιυπερτασικών φαρμάκων και αλληλεπιδράσεις τους με λιποειδείς διπλοστιβάδες με χρήση φυσικοχημικών μεθόδων. (Doctoral Dissertation). University of Patras. Retrieved from http://hdl.handle.net/10889/6192

Chicago Manual of Style (16th Edition):

Ντουντανιώτης, Δημήτριος. “Διαμορφωτική μελέτη αντιυπερτασικών φαρμάκων και αλληλεπιδράσεις τους με λιποειδείς διπλοστιβάδες με χρήση φυσικοχημικών μεθόδων.” 2012. Doctoral Dissertation, University of Patras. Accessed May 20, 2019. http://hdl.handle.net/10889/6192.

MLA Handbook (7th Edition):

Ντουντανιώτης, Δημήτριος. “Διαμορφωτική μελέτη αντιυπερτασικών φαρμάκων και αλληλεπιδράσεις τους με λιποειδείς διπλοστιβάδες με χρήση φυσικοχημικών μεθόδων.” 2012. Web. 20 May 2019.

Vancouver:

Ντουντανιώτης . Διαμορφωτική μελέτη αντιυπερτασικών φαρμάκων και αλληλεπιδράσεις τους με λιποειδείς διπλοστιβάδες με χρήση φυσικοχημικών μεθόδων. [Internet] [Doctoral dissertation]. University of Patras; 2012. [cited 2019 May 20]. Available from: http://hdl.handle.net/10889/6192.

Council of Science Editors:

Ντουντανιώτης . Διαμορφωτική μελέτη αντιυπερτασικών φαρμάκων και αλληλεπιδράσεις τους με λιποειδείς διπλοστιβάδες με χρήση φυσικοχημικών μεθόδων. [Doctoral Dissertation]. University of Patras; 2012. Available from: http://hdl.handle.net/10889/6192

5. 萩原, 里絵. 有機アニオン系薬剤のトランスポーターを介した輸送機構と薬物相互作用 : Transporter-mediated transport mechanism and drug-drug interaction of organic anion drugs.

Degree: Chiba University / 千葉大学

研究科: 千葉大学大学院薬学研究院

修了年:2007

学位:千大院薬博乙第薬10号

Advisors/Committee Members: 千葉大学大学院薬学研究院.

Subjects/Keywords: 有機アニオン; トランスポーター; オルメサルタン; プラバスタチン; 薬物相互作用; Organic anion; transporter; olmesartan; pravastatin; drug-drug interaction

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

萩原, . (n.d.). 有機アニオン系薬剤のトランスポーターを介した輸送機構と薬物相互作用 : Transporter-mediated transport mechanism and drug-drug interaction of organic anion drugs. (Thesis). Chiba University / 千葉大学. Retrieved from http://opac.ll.chiba-u.jp/da/curator/900047146/

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

萩原, 里絵. “有機アニオン系薬剤のトランスポーターを介した輸送機構と薬物相互作用 : Transporter-mediated transport mechanism and drug-drug interaction of organic anion drugs.” Thesis, Chiba University / 千葉大学. Accessed May 20, 2019. http://opac.ll.chiba-u.jp/da/curator/900047146/.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

萩原, 里絵. “有機アニオン系薬剤のトランスポーターを介した輸送機構と薬物相互作用 : Transporter-mediated transport mechanism and drug-drug interaction of organic anion drugs.” Web. 20 May 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

萩原 . 有機アニオン系薬剤のトランスポーターを介した輸送機構と薬物相互作用 : Transporter-mediated transport mechanism and drug-drug interaction of organic anion drugs. [Internet] [Thesis]. Chiba University / 千葉大学; [cited 2019 May 20]. Available from: http://opac.ll.chiba-u.jp/da/curator/900047146/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

萩原 . 有機アニオン系薬剤のトランスポーターを介した輸送機構と薬物相互作用 : Transporter-mediated transport mechanism and drug-drug interaction of organic anion drugs. [Thesis]. Chiba University / 千葉大学; Available from: http://opac.ll.chiba-u.jp/da/curator/900047146/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


Universidade do Rio Grande do Sul

6. Bajerski, Lisiane. Olmesartana medoxomila : validação de metodologia analítica, avaliação biofarmacêutica e análise polimórfica.

Degree: 2010, Universidade do Rio Grande do Sul

 O pró-fármaco olmesartana medoxomila (OLM) é um anti-hipertensivo representante da classe dos bloqueadores seletivos dos receptores da angiotensina II (BRA). No Brasil, encontra-se disponível sob… (more)

Subjects/Keywords: Olmesartan medoxomil; Olmesartana medoxomila; Validação : Métodos de análise de fármacos; High-performance liquid chromatography; Micellar electrokinetic chromatography; Cromatografia liquida de alta eficiencia (clae); Cinética de dissolução; Dissolution kinetic; Cromatografia capilar eletrocinética micelar; Polymorphism; Polimorfismo

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bajerski, L. (2010). Olmesartana medoxomila : validação de metodologia analítica, avaliação biofarmacêutica e análise polimórfica. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/32799

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bajerski, Lisiane. “Olmesartana medoxomila : validação de metodologia analítica, avaliação biofarmacêutica e análise polimórfica.” 2010. Thesis, Universidade do Rio Grande do Sul. Accessed May 20, 2019. http://hdl.handle.net/10183/32799.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bajerski, Lisiane. “Olmesartana medoxomila : validação de metodologia analítica, avaliação biofarmacêutica e análise polimórfica.” 2010. Web. 20 May 2019.

Vancouver:

Bajerski L. Olmesartana medoxomila : validação de metodologia analítica, avaliação biofarmacêutica e análise polimórfica. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2010. [cited 2019 May 20]. Available from: http://hdl.handle.net/10183/32799.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bajerski L. Olmesartana medoxomila : validação de metodologia analítica, avaliação biofarmacêutica e análise polimórfica. [Thesis]. Universidade do Rio Grande do Sul; 2010. Available from: http://hdl.handle.net/10183/32799

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

.